investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
Thomas Waldmann
4 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
The bio-physics of the gamma cytokine receptors on T-leukemic cells.
Related projects
Scott W Lowe
The impact of chromosome 17p lesions on leukemogeneis and therapy response
Leukaemia
Pathology
Hematology and hematologic malignancies
Alan Rein
Retrovirus Assembly and Maturation
Leukaemia
Pathology
Hematology and hematologic malignancies
Ashley Marie Pandolfi
Unraveling crucial roles of homeobox gene Hlx in hematopoiesis and leukemogenesis
Leukaemia
Hematology and hematologic malignancies
Robert Kreitman
Development of Recombinant Toxins to Treat Hematologic Malignancies
Leukaemia
Hematology and hematologic malignancies
Suresh Ambudkar
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
Leukaemia
Pathology
Hematology and hematologic malignancies
Seth J Corey
Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML
Leukaemia
Hematology and hematologic malignancies
Derrick J. Rossi
Reprogramming committed blood cells to a hematopoietic stem cell fate
Leukaemia
Hematology and hematologic malignancies
Katy Rezvani
Curative Cell-based Therapies for Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
David A Williams
Rac proteins in hematopoietic cell survival and function
Leukaemia
Hematology and hematologic malignancies
